These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8192584)

  • 1. The impact of genetic polymorphisms in risk assessment of drugs.
    Poulsen HE; Loft S
    Arch Toxicol Suppl; 1994; 16():211-22. PubMed ID: 8192584
    [No Abstract]   [Full Text] [Related]  

  • 2. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
    Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
    [No Abstract]   [Full Text] [Related]  

  • 4. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping of drug metabolism in infants and children: potentials and problems.
    Rane A
    Pediatrics; 1999 Sep; 104(3 Pt 2):640-3. PubMed ID: 10469807
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.
    Hippius M; Buchardt C; Farker K; Kuhn UD; Reimann IR; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):417-21. PubMed ID: 12877354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for differences in susceptibility to toxicants: introduction.
    Boobis AR
    Toxicol Lett; 1992 Dec; 64-65 Spec No():109-13. PubMed ID: 1471164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxicology and pharmacogenetics].
    Dalhoff KP; Poulsen HE
    Ugeskr Laeger; 2005 May; 167(20):2170-2. PubMed ID: 15987076
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular modeling of cytochrome P450 and drug metabolism.
    Wang JF; Chou KC
    Curr Drug Metab; 2010 May; 11(4):342-6. PubMed ID: 20446905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse drug reactions. Hereditary differences in drug metabolism].
    Collette D; Thürmann PA
    Dtsch Med Wochenschr; 2002 May; 127(19):1025-8. PubMed ID: 11997871
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of studies of selected metabolic polymorphisms and cancer.
    d'Errico A; Malats N; Vineis P; Boffetta P
    IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.
    Morrison A; Levy R
    Pharmacogenomics; 2004 Sep; 5(6):673-89. PubMed ID: 15335288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of drug metabolism.
    Meyer UA
    Fundam Clin Pharmacol; 1990; 4(6):595-615. PubMed ID: 1982880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of the cytochromes P450.
    Daly AK
    Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics.
    Ingelman-Sundberg M
    Arch Toxicol Suppl; 1997; 19():3-13. PubMed ID: 9079190
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.
    Ashton LJ; Murray JE; Haber M; Marshall GM; Ashley DM; Norris MD
    Pharmacogenet Genomics; 2007 Sep; 17(9):709-17. PubMed ID: 17700360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.